No evidence of neurocognitive adverse events associated...

No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data

Harvey, Philip D, Sabbagh, Marwan N, Harrison, John E, Ginsberg, Henry N, Chapman, M John, Manvelian, Garen, Moryusef, Angele, Mandel, Jonas, Farnier, Michel
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
39
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/ehx661
Date:
February, 2018
File:
PDF, 655 KB
english, 2018
Conversion to is in progress
Conversion to is failed